CliffBio
small molecule

AMPHOTERICIN B

AMPHOTERICIN B

Loss of exclusivity—loss of exclusivity
CompanySUN PHARMA INDUSTRIES LTD

Drug detail

Brand nameAMPHOTERICIN B
Active ingredientAMPHOTERICIN B
Strength50MG/VIAL
Dosage formINJECTABLE, LIPOSOMAL
RouteINJECTION
ModalitySmall molecule
FDA approvalDecember 2021
Marketing statusRX

More from SUN PHARMA INDUSTRIES LTD

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

AMPHOTERICIN B patent cliff — loss of exclusivity — | CliffBio